 |
Marc Ghany, MD, MHSc
Staff Physician, Liver Diseases Branch
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Bethesda, Maryland
|
HBRN and the Current Status of HBV Therapy; February 11, 2014; This program is available for CME Credit |
|
|
Jody Gilmore, MSN, CRNP
Coordinator
Viral Hepatitis Program at Penn Presbyterian Medical Center
Nurse Practitioner
Perelman School of Medicine at the University of Pennsylvania
|
Real Cases from the University of Pennsylvania; November 12, 2014; This program is available for CME Credit
|
|
|
Robert G. Gish, MD
Senior Medical Director
St Joseph’s Medical Center
Phoenix, Arizona
Professor of Clinical Medicine University of Nevada
Las Vegas, Nevada
|
What's on the Horizon for Treatment for CHB? New Targets for HBV?; January 15th, 2014, This program is available for CME Credit
|
|
|
Jeffrey S. Glenn, MD, PhD
Associate Professor of Medicine and Microbiology & Immunology Division of Gastroenterology Hepatology Director
Center for Hepatitis and Liver Tissue Engineering Stanford University School of Medicine
Palo Alto, California
|
Prenylation-inhibition based anti-HDV therapy; December 3, 2014; This program is available for CME Credit
|
|
|
Camilla Graham, MD, MPH
Division of Infectious Disease
Harvard Medical School
Viral Hepatitis Center
Beth Israel Deaconess Medical Center
Boston, Massachusetts
|
Improving Patient Care in Hepatitis C through Lessons Learned from Industry, December 4th, 2013, This program is NOT available for CME Credit
|
